Cancer Management and Research
Volume 14, 2022 - Issue
Open access
147
Views
0
CrossRef citations to date
0
Altmetric
Original Research
Development and Multicentre Validation of the Modena Score to Predict Survival in Advanced Biliary Cancers Undergoing Second-Line Chemotherapy
Massimiliano Salati1 Division of Oncology, Department of Oncology and Hematology, University Hospital of Modena, Modena, Italy;2 PhD Program Clinical and Experimental Medicine, University of Modena and Reggio Emilia, Modena, ItalyCorrespondence[email protected]
View further author information
, View further author information
Luigi Marcheselli1 Division of Oncology, Department of Oncology and Hematology, University Hospital of Modena, Modena, ItalyView further author information
, Carlo Messina3 Department of Medical Oncology, Santa Chiara Hospital, Trento, Italy
https://orcid.org/0000-0002-7934-1419View further author information
Valeria Merz3 Department of Medical Oncology, Santa Chiara Hospital, Trento, Italy;4 Digestive Molecular Clinical Oncology Research Unit, University of Verona, Verona, ItalyView further author information
, Marco Messina5 Oncology Unit, Fondazione San Raffaele-Giglio, Cefalu’, Palermo, ItalyView further author information
, Pietro Carotenuto6 Telethon Institute of Genetics and Medicine, Pozzuoli, 80078, Napoli, Italy
https://orcid.org/0000-0002-6622-183XView further author information
Francesco Caputo1 Division of Oncology, Department of Oncology and Hematology, University Hospital of Modena, Modena, ItalyView further author information
, Fabio Gelsomino1 Division of Oncology, Department of Oncology and Hematology, University Hospital of Modena, Modena, ItalyView further author information
, Andrea Spallanzani1 Division of Oncology, Department of Oncology and Hematology, University Hospital of Modena, Modena, ItalyView further author information
, Luca Reggiani Bonetti7 Pathology Section, University Hospital of Modena, Modena, ItalyView further author information
, Stefania Caramaschi7 Pathology Section, University Hospital of Modena, Modena, ItalyView further author information
, Gabriele Luppi1 Division of Oncology, Department of Oncology and Hematology, University Hospital of Modena, Modena, ItalyView further author information
, Massimo Dominici1 Division of Oncology, Department of Oncology and Hematology, University Hospital of Modena, Modena, Italy
https://orcid.org/0000-0002-4007-1503View further author information
Michele Ghidini8 Medical Oncology Unit, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, ItalyView further author information
show all
Pages 983-993
|
Published online: 05 Mar 2022
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.